Search results
U.S. FDA grants full approval to Pfizer COVID vaccine for ages 12-15
Reuters via Yahoo News· 2 years agoThe vaccine, sold under the brand name Comirnaty for adults, has been available under an emergency...
No evidence the Pfizer COVID-19 vaccine is connected to the monkeypox outbreak
Austin American-Statesman via Yahoo News· 2 years agoHow are monkeypox cases, COVID-19 vaccines and shingles infections connected? They are not. But if...
Pfizer (PFE) Seeks FDA Approval for Omicron Booster in Kids
Zacks via Yahoo Finance· 2 years agoPfizer (PFE) and partner BioNTech seek authorization from the FDA for using their bivalent COVID-19...
Vaccine aimed at preventing meningitis in kids approved by FDA. What happens next?
Miami Herald via Yahoo News· 8 months agoA new vaccine from Pfizer has been approved by the Food and Drug Administration as the first shot of...
PFE, BNTX's COVID Jab Gets FDA's Full Nod for Adolescents
Zacks via Yahoo Finance· 2 years agoPfizer (PFE) and partner BioNTech's (BNTX) Comirnaty is the first COVID-19 vaccine to receive full...
GSK outpaces Pfizer in RSV vaccine market
BioPharma Dive via Yahoo Finance· 8 months agoDive Brief: GSK said Wednesday that its new Arexvy vaccine for respiratory syncytial virus pulled in 709 million pounds, or about $860 million, in its...
Pfizer's (PFE) Ulcerative Colitis Pill Velsipity Gets EU Nod
Zacks via Yahoo Finance· 4 months agoPfizer PFE announced that the European Commission has granted marketing approval to its oral,...
Pharma Stock Roundup: MRK Buys Cancer Drug Rights, SNY Dupixent Kids Study Succeeds
Zacks via Yahoo Finance· 2 years agoThis week, Merck MRK in-licensed co-development rights to Orion Corporation’s prostate cancer...
Pfizer (PFE) Q1 Earnings Beat, COVID Jab Sales Down as Expected
Zacks via Yahoo Finance· 1 year agoPfizer PFE reported first-quarter 2023 adjusted earnings per share of $1.23, which beat the Zacks...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoDespite a bevy of promising updates for its cancer treatments, Pfizer stock remained trapped below a...